Jiangsu Kanion Pharmaceutical Co.,Ltd. (SHA:600557)
China flag China · Delayed Price · Currency is CNY
12.46
-0.28 (-2.20%)
May 20, 2026, 11:29 AM CST

SHA:600557 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
2,0362,1482,1951,9791,601937.44
Trading Asset Securities
--40460170176
Cash & Short-Term Investments
2,0362,1482,2352,4391,7711,113
Cash Growth
-5.05%-3.89%-8.36%37.70%59.08%43.98%
Accounts Receivable
623.76599.59700.541,0921,4711,350
Other Receivables
7.511.576.335.489.6711.75
Receivables
631.26611.16706.871,0981,4801,362
Inventory
457.6452.56540.27350.11342.82338.08
Other Current Assets
81.58101.28113.69188.65135.3260.91
Total Current Assets
3,2063,3133,5964,0763,7302,874
Property, Plant & Equipment
3,0002,8992,7522,5392,5082,533
Long-Term Investments
4.1411.115.3415.3245.6160.64
Goodwill
58.9958.9958.9958.9958.9958.99
Other Intangible Assets
235.68239.07171.46198.17231.15282.73
Long-Term Deferred Tax Assets
46.8845.1345.3146.2215.9616.77
Long-Term Deferred Charges
212.76215.54203.84192.67184.79171.14
Other Long-Term Assets
12280.6764.462.8121.6320.72
Total Assets
6,8876,8636,9077,1896,7966,018
Accounts Payable
236.75226.39226.87236.61373.36359.75
Accrued Expenses
14.02712.4880.741,030814.57531.14
Short-Term Debt
-406.3486.08422.74-234.5
Current Portion of Leases
-0.25----
Current Income Taxes Payable
29.132.032.142.422.12.05
Current Unearned Revenue
30.9827.7425.4625.17214.8725.34
Other Current Liabilities
1,346346.07423.19325.68376.2300.08
Total Current Liabilities
1,6571,7212,0442,0421,7811,453
Long-Term Debt
--1.931.931.931.93
Long-Term Leases
0.810.81----
Long-Term Unearned Revenue
136.36128.22155.27126.1678.7890.52
Total Liabilities
1,7941,8502,2022,1711,8621,545
Common Stock
566.16566.16581.8584.75584.6592.88
Additional Paid-In Capital
---178.2998.13171.79
Retained Earnings
4,3324,2524,1454,2254,1363,720
Treasury Stock
---211.98-48.14-64.7-180
Total Common Equity
4,8984,8194,5154,9404,7544,304
Minority Interest
194.77193.89190.5178.47179.8168.35
Shareholders' Equity
5,0935,0124,7055,0194,9344,473
Total Liabilities & Equity
6,8876,8636,9077,1896,7966,018
Total Debt
0.81407.36488.01424.661.93236.43
Net Cash (Debt)
2,0351,7411,7472,0141,769877.01
Net Cash Growth
-5.00%-0.36%-13.27%13.84%101.75%209.48%
Net Cash Per Share
3.603.093.033.473.051.53
Filing Date Shares Outstanding
566.26566.16569.46583.9594.68576.43
Total Common Shares Outstanding
566.26566.16569.46583.9594.68576.43
Working Capital
1,5491,5921,5512,0331,9491,421
Book Value Per Share
8.658.517.938.467.997.47
Tangible Book Value
4,6034,5204,2844,6834,4643,963
Tangible Book Value Per Share
8.137.987.528.027.516.87
Buildings
-2,6502,4832,4022,4602,398
Machinery
-1,5091,3401,3181,2331,191
Construction In Progress
-438.98472.81227.2598.5482.9
Source: S&P Global Market Intelligence. Standard template. Financial Sources.